AE Preferred Term, % (n) | Crossover Phase (Randomized Population) | |
---|---|---|
 | LDX-All Doses (n = 115) a | Placebo (n = 117) a |
Any TEAE | 27.8 (32) | 35.9 (42) |
Anxiety | 1.7 (2) | 0 |
Decreased appetite | 3.5 (4) | 1.7 (2) |
Dry mouth | 3.5 (4) | 0.9 (1) |
Fatigue | 0.9 (1) | 12.0 (14) |
Feeling jittery | 0 | 0 |
Headache | 1.7 (2) | 2.6 (3) |
Insomnia | 2.6 (3) | 1.7 (2) |
Irritability | 0 | 0.9 (1) |
Nausea | 1.7 (2) | 0 |
Upper respiratory tract infection | 1.7 (2) | 7.7 (9) |